Meningococcal serogroup B vaccines: Estimating breadth of coverage

Neisseria meningitidis serogroup B (MenB) is an important cause of invasive meningococcal disease. The development of safe and effective vaccines with activity across the diversity of MenB strains has been challenging. While capsular polysaccharide conjugate vaccines have been highly successful in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Donald, Robert G. K., Hawkins, Julio Cesar, Hao, Li, Liberator, Paul, Jones, Thomas R., Harris, Shannon L., Perez, John L., Eiden, Joseph J., Jansen, Kathrin U., Anderson, Annaliesa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328210/
https://www.ncbi.nlm.nih.gov/pubmed/27960595
http://dx.doi.org/10.1080/21645515.2017.1264750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328210/
https://www.ncbi.nlm.nih.gov/pubmed/27960595
http://dx.doi.org/10.1080/21645515.2017.1264750

Ejemplares similares